Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 January 2008

Heart. Published Online First: 29 March 2007. doi:10.1136/hrt.2006.103358
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

Reviews

Circulating stem/progenitor cells in stable ischemic heart disease and acute coronary syndromes - relevant reparatory mechanism?

Wojciech Wojakowski 1*, Magda Kucia 2, Maciej Kazmierski 1, Mariusz Z Ratajczak 2 and Michal Tendera 1

1 III Division of Cardiology, Silesian School of Medicine, Poland
2 Stem Cell Biology Program, University of Louisville, United States

* To whom correspondence should be addressed. E-mail: wojwoj{at}mp.pl.

Accepted 6 February 2007


Abstract

Bone marrow-derived cells which may be involved in the cardiac repair/regeneration after ischemic injury must undergo mobilization into peripheral blood with subsequent homing and engraftment into the target organ. <BR> The mobilization of the heterogenous population of stem/progenitor cells (endothelial progenitors, hematopoietic progenitors, mesenchymal stem cells) in the setting of endothelial injury or myocardial ischemia was described recently. Number of circulating stem/progenitor reflect the endothelial damage and turnover may be a surrogate marker which reflects the burden of cardiovascular risk factors and prognostic marker in stable coronary heart disease as well as acute coronary syndromes. Acute coronary syndromes are associated with increased levels of inflammatory and hematopoietic cytokines which in turn can mobilize the progenitor cells from the bone marrow. Myocardial infarction induces the increase of the number of EPC as well as other less well defined subpopulatons, such as CD34/ c-kit+ and CD34/CXCR4+ cells which may take part in cardiac repair after ischemic injury. This review summarizes the data on mobilization of stem/progenitor cells in acute coronary syndromes. It discusses the cell types, mechanisms of mobilization, homing and engraftment as well as the relevance to clinical outcomes.

Keywords: chemokines, endothelial progenitors, mobilization, myocardial infarction, stem cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Moreno, P. R., Sanz, J., Fuster, V. (2009). Promoting Mechanisms of Vascular Health: Circulating Progenitor Cells, Angiogenesis, and Reverse Cholesterol Transport. J Am Coll Cardiol 53: 2315-2323 [Abstract] [Full Text]  
  • Tendera, M., Wojakowski, W., Ruzyllo, W., Chojnowska, L., Kepka, C., Tracz, W., Musialek, P., Piwowarska, W., Nessler, J., Buszman, P., Grajek, S., Breborowicz, P., Majka, M., Ratajczak, M. Z., for the REGENT Investigators (REGENT investigators, (2009). Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30: 1313-1321 [Abstract] [Full Text]  
  • Wojakowski, W., Kucia, M., Milewski, K., Machalinski, B., Halasa, M., Buszman, P., Klimeczek, P., Kazmierski, M., Pasowicz, M., Ratajczak, M. Z., Tendera, M. (2008). The role of CXCR4/SDF-1, CD117/SCF, and c-met/HGF chemokine signalling in the mobilization of progenitor cells and the parameters of the left ventricular function, remodelling, and myocardial perfusion following acute myocardial infarction. Eur Heart J Suppl 10: K16-K23 [Abstract] [Full Text]  
  • Yao, K, Huang, R, Qian, J, Cui, J, Ge, L, Li, Y, Zhang, F, Shi, H, Huang, D, Zhang, S, Sun, A, Zou, Y, Ge, J (2008). Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 94: 1147-1153 [Abstract] [Full Text]  
  • Rochefort, G Y (2008). Circulating progenitor cells in coronary heart disease. Heart 94: 793-794 [Full Text]  
  • Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M. G., Garry, D. J., Longgood, J., Frantz, D. E., Olson, E. N., Hsieh, J., Schneider, J. W. (2008). Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl. Acad. Sci. USA 105: 6063-6068 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Hypoxia-induced Mesenchymal Stem Cells mobilization
Gael Y Rochefort
Online, 7 Jan 2008 [Full text]
Author's Response
Wojtek Wojakowski, et al.
Online, 7 Jan 2008 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.